![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Schuster, Sebastian; Beyer, Leonie; Palleis, Carla; Harris, Stefanie; Schmitt, Julia; Weidinger, Endy; Prix, Catharina; Bötzel, Kai; Danek, Adrian; Rauchmann, Boris-Stephan; Stöcklein, Sophia; Lindner, Simon; Unterrainer, Marcus; Albert, Nathalie L.; Mittlmeier, Lena M.; Wetzel, Christian; Rupprecht, Rainer; Rominger, Axel; Bartenstein, Peter; Perneczky, Robert; Levin, Johannes; Höglinger, Günter U.; Brendel, Matthias und Dekorsy, Franziska J.
(2022):
Impact of Partial Volume Correction on [F-18]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome.
In: Brain Sciences, Bd. 12, Nr. 2
[PDF, 1MB]
Mittlmeier, Lena M.; Brendel, Matthias; Beyer, Leonie; Albert, Nathalie L.; Todica, Andrei; Zacherl, Mathias J.; Wenter, Vera; Herlemann, Annika; Kretschmer, Alexander; Ledderose, Stephan T.; Schmidt-Hegemann, Nina-Sophie; Kunz, Wolfgang G.; Ricke, Jens; Bartenstein, Peter; Ilhan, Harun und Unterrainer, Marcus
(21. Mai 2021):
Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients.
In: Frontiers in Oncology, Bd. 11, 663631
[PDF, 2MB]
Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Käsmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European journal of nuclear medicine and molecular imaging
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European journal of nuclear medicine and molecular imaging
[PDF, 3MB]
Beyer, Leonie; Gosewisch, Astrid; Lindner, Simon; Völter, Friederike; Mittlmeier, Lena M.; Tiling, Reinhold; Brendel, Matthias; Cyran, Clemens C.; Unterrainer, Marcus; Rübenthaler, Johannes; Auernhammer, Christoph J.; Spitzweg, Christine; Böning, Guido; Gildehaus, F. J.; Jurkschat, Klaus; Wängler, Carmen; Wängler, Björn; Schirrmacher, Ralf; Wenter, Vera; Todica, Andrei; Bartenstein, Peter und Ilhan, Harun
(2021):
Dosimetry and optimal scan time of 18FSiTATE-PET/CT in patients with neuroendocrine tumours.
In: European journal of nuclear medicine and molecular imaging, Bd. 48: S. 3571-3581
[PDF, 2MB]
Mittlmeier, Lena M.; Todica, Andrei; Gildehaus, Franz-Josef; Unterrainer, Marcus; Beyer, Leonie; Brendel, Matthias; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Ledderose, Stephan T.; Vettermann, Franziska J.; Schott, Melanie; Rodler, Severin; Marcon, Julian; Ilhan, Harun; Cyran, Clemens C.; Stief, Christian G.; Staehler, Michael und Bartenstein, Peter
(2021):
68Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 804kB]
ORCID: https://orcid.org/0000-0003-0953-7624; Ledderose, Stephan T.; Vettermann, Franziska J.; Schott, Melanie; Rodler, Severin; Marcon, Julian; Ilhan, Harun; Cyran, Clemens C.; Stief, Christian G.; Staehler, Michael und Bartenstein, Peter
(2021):
68Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 804kB]
Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2021):
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
In: European journal of nuclear medicine and molecular imaging
[PDF, 848kB]
Beyer, Leonie; Gosewisch, Astrid; Lindner, Simon; Voelter, Friederike; Mittlmeier, Lena M.; Tiling, Reinhold; Brendel, Matthias; Cyran, Clemens C.; Unterrainer, Marcus; Ruebenthaler, Johannes; Auernhammer, Christoph J.; Spitzweg, Christine; Boening, Guido; Gildehaus, F. J.; Jurkschat, Klaus; Wangler, Carmen; Wangler, Bjoern; Schirrmacher, Ralf; Wenter, Vera; Todica, Andrei; Bartenstein, Peter und Ilhan, Harun
(2021):
Dosimetry and optimal scan time of [F-18]SiTATE-PET/CT in patients with neuroendocrine tumours.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 11: S. 3571-3581
Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 12: S. 3975-3989
Mittlmeier, Lena M.; Suchorska, Bogdana; Ruf, Viktoria; Holzgreve, Adrien; Brendel, Matthias; Herms, Jochen; Bartenstein, Peter; Tonn, Jörg C.; Unterrainer, Marcus und Albert, Nathalie L.
(2021):
F-18-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.
In: Cancers, Bd. 13, Nr. 13, 3163
Mittlmeier, Lena M.; Todica, Andrei; Gildehaus, Franz-Josef; Unterrainer, Marcus; Beyer, Leonie; Brendel, Matthias; Albert, Nathalie L.; Ledderose, Stephan T.; Vettermann, Franziska J.; Schott, Melanie; Rodler, Severin; Marcon, Julian; Ilhan, Harun; Cyran, Clemens C.; Stief, Christian G.; Staehler, Michael und Bartenstein, Peter
(2021):
Ga-68-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 5: S. 1711-1720
Unterrainer, Marcus; Taugner, Julian; Kasmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2021):
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy +/- immune checkpoint inhibition.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 49, Nr. 4: S. 1407-1416
Mittlmeier, Lena M.; Unterrainer, Marcus; Rodler, S.; Todica, A.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Burgard, C.; Cyran, C. C.; Kunz, W. G.; Ricke, J.; Bartenstein, P.; Stief, C. G.; Ilhan, H. und Staehler, Michael
(2020):
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624; Burgard, C.; Cyran, C. C.; Kunz, W. G.; Ricke, J.; Bartenstein, P.; Stief, C. G.; Ilhan, H. und Staehler, Michael
(2020):
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 2MB]
Neuerburg, Carl; Mittlmeier, Lena M.; Keppler, Alexander M.; Westphal, Ines; Glass, Änne; Saller, Maximilian M.; Herlyn, Philipp K. E.; Richter, Heiko; Böcker, Wolfgang; Schieker, Matthias; Aszodi, Attila und Fischer, Dagmar-C.
(2019):
Growth factor-mediated augmentation of long bones: evaluation of a BMP-7 loaded thermoresponsive hydrogel in a murine femoral intramedullary injection model.
In: Journal of Orthopaedic Surgery and Research
14:297
[PDF, 1MB]